医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
URGN · UroGen Pharma Ltd.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
UroGen Pharma Ltd.（URGN）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $3.4M；高管董事有效买入 —、有效卖出 $2.9M。最近申报 2026-10-09。
买入 Bought—
卖出 Sold$3.4M
有效买入 Effective bought—
有效卖出 Effective sold$2.9M
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-08 | Degnan Chris Chief Financial Officer | 卖出 Sell | 2,202 | $36.69 | $81K | SEC |
| 2026-09-08 | Schoenberg Mark Chief Medical Officer | 卖出 Sell | 871 | $42.92 | $37K | SEC |
| 2026-09-08 | Smith Jason Drew General Counsel | 卖出 Sell | 1,519 | $42.54 | $65K | SEC |
| 2026-08-20 | Schoenberg Mark Chief Medical Officer | 卖出 Sell · 有效 | 60,677 | $47.05 | $2.9M | SEC |
| 2026-07-09 | Schoenberg Mark Chief Medical Officer | 卖出 Sell | 10,000 | $40.00 | $400K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-08 | Degnan Chris Officer | 2,202 | $90K | |
| 2026-09-08 | Smith Jason Drew Officer | 1,519 | $67K | |
| 2026-09-08 | Schoenberg Mark Officer | 871 | $38K | |
| 2026-08-20 | Schoenberg Mark Officer | 60,677 | $2.9M | |
| 2026-07-09 | Schoenberg Mark Officer | 10,000 | $400K | 10b5-1 |
内部人 Insiders
Degnan Chris、Schoenberg Mark、Smith Jason Drew